Comparison
Abacavir Hypersensitivity C5768819 vs 3 4 Toe Syndactyly C1834062
Clinical comparison between Abacavir Hypersensitivity and 3 4 Toe Syndactyly for differential diagnosis and treatment planning.
Abacavir Hypersensitivity C5768819
A potentially serious immune reaction to the HIV drug abacavir. Genetic testing is required before starting treatment to identify those at risk of this reaction.
3 4 Toe Syndactyly C1834062
Webbing between the third and fourth toes, a common birth variation. Often requires no treatment as toes usually function normally.
6 comparison axes
Onset
Abacavir Hypersensitivity C5768819
Variable
3 4 Toe Syndactyly C1834062
0-0
Onset patterns differ
Severity
Abacavir Hypersensitivity C5768819
severe
3 4 Toe Syndactyly C1834062
mild
Different severity levels
Chronic
Abacavir Hypersensitivity C5768819
Acute
3 4 Toe Syndactyly C1834062
Chronic
Differing course
Communicable
Abacavir Hypersensitivity C5768819
No
3 4 Toe Syndactyly C1834062
No
Different transmission
Body System
Abacavir Hypersensitivity C5768819
immunologic
3 4 Toe Syndactyly C1834062
musculoskeletal
Same/different system
Category
Abacavir Hypersensitivity C5768819
immunologic
3 4 Toe Syndactyly C1834062
genetic
Different category
Bottom line
abacavir-hypersensitivity-C5768819 and 3-4-toe-syndactyly-C1834062 differ in severity, chronicity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abacavir Hypersensitivity C5768819 | 3 4 Toe Syndactyly C1834062 | Discriminating power |
|---|---|---|---|
| Timing of appearance | Occurs after abacavir exposure; timing varies and is not congenital. | Present from birth as webbing between the third and fourth toes. | High |
| Systemic illness | May involve fever, rash, or other systemic features; exact pattern is not fixed. | Usually a localized toe finding without systemic illness. | High |
| Functional effect | Can become severe and requires urgent clinical assessment. | Often mild, with toes that usually function normally. | Moderate |
When to favor each condition
Choose Abacavir Hypersensitivity C5768819 when
New symptoms after starting abacavir
The history links an immune reaction to drug exposure rather than a birth variation.
High
Fever, rash, or worsening systemic symptoms
These features fit a potentially serious reaction and need clinician review.
Moderate
Known HLA-B*5701 risk context
Pre-treatment genetic testing identifies risk but does not by itself diagnose a reaction.
Moderate
Choose 3 4 Toe Syndactyly C1834062 when
Webbing noticed at birth
Congenital onset supports syndactyly rather than a drug reaction.
High
Isolated third-to-fourth toe involvement
A localized musculoskeletal finding matches the supplied description.
High
Normal toe function and no systemic symptoms
Mild course and preserved function favor observation unless concerns arise.
Moderate
How key tests differ
| Test | Abacavir Hypersensitivity C5768819 | 3 4 Toe Syndactyly C1834062 | Interpretation |
|---|---|---|---|
| HLA-B*5701 testing | Used before abacavir to identify increased hypersensitivity risk. | Not relevant to toe syndactyly. | A risk result is not a diagnosis of hypersensitivity. |
| Clinical examination | Looks for evolving systemic features after drug exposure. | Shows webbing between the third and fourth toes. | Examination distinguishes an acute reaction from a congenital finding. |
| Imaging or specialist assessment | Not routinely defining; selected tests depend on symptoms. | May be considered if function, alignment, or associated anomalies are uncertain. | No single test replaces clinician interpretation. |
Prognosis comparison
Abacavir Hypersensitivity C5768819
- Outcome
- Potentially serious but outcome depends on recognition and stopping the implicated drug under care.
- Factors
- Exposure history, symptom progression, and timely clinician management.
3 4 Toe Syndactyly C1834062
- Outcome
- Usually favorable, with normal toe function and often no treatment.
- Factors
- Degree of webbing, function, and any associated anomalies.
Time frame: Reaction is acute; syndactyly is lifelong but commonly stable.
These conditions are unrelated, so prognosis should be judged separately.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute deterioration | A severe immune reaction may progress and requires urgent care. Acute deterioration is not expected from isolated toe webbing. Severity differs markedly. |
| Functional limitation | Illness may temporarily limit activity during the reaction. Toe function is usually preserved; limitation is uncommon. Impact depends on individual findings. |
| Associated conditions | Occurs in the context of HIV treatment, not as a congenital limb variation. May occur alone; broader syndromes are not established by this finding alone. Clinician review is needed if other anomalies exist. |
Patient education highlights
- HighDrug warning
Seek urgent care for suspected abacavir hypersensitivity and do not restart abacavir unless a clinician directs it.
- MediumBirth variation
Third-to-fourth toe webbing often needs no treatment when function is normal.
- MediumWhen to reassess
Report new systemic symptoms, skin changes, pain, or reduced toe function for clinical interpretation.